Your browser doesn't support javascript.
loading
Predicting prognosis and evaluating the benefits of adjuvant chemotherapy depending on the tumor location in intrahepatic cholangiocarcinoma: focusing on the involvement of below 2nd bile duct confluence.
Sohn, Hee Ju; Kim, Hongbeom; Kim, Jae Ri; Kang, Jae Sung; Han, Youngmin; Lee, Mirang; Kim, Hyeong Seok; Kwon, Wooil; Hong, Suk Kyun; Choi, YoungRok; Yi, Nam-Joon; Lee, Kwang-Woong; Suh, Kyung-Suk; Jang, Jin-Young.
Affiliation
  • Sohn HJ; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Kim H; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Kim JR; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Kang JS; Department of Surgery, Gyeongsang National University Changwon Hospital, Changwon, Korea.
  • Han Y; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Lee M; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Kim HS; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Kwon W; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Hong SK; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Choi Y; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Yi NJ; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Lee KW; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Suh KS; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Jang JY; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Ann Surg Treat Res ; 102(5): 248-256, 2022 May.
Article in En | MEDLINE | ID: mdl-35611087

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Year: 2022 Type: Article